Thrive Capital Management, LLC Gilead Sciences, Inc. Transaction History
Thrive Capital Management, LLC
- $218 Million
- Q4 2024
A detailed history of Thrive Capital Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Thrive Capital Management, LLC holds 28,185 shares of GILD stock, worth $2.93 Million. This represents 1.19% of its overall portfolio holdings.
Number of Shares
28,185
Previous 25,332
11.26%
Holding current value
$2.93 Million
Previous $2.12 Million
22.61%
% of portfolio
1.19%
Previous 1.0%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
2,082Shares Held
1.02BCall Options Held
8.81MPut Options Held
9.7M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...